pI: 8.0416 |
Length (AA): 171 |
MW (Da): 18953 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
2 | 171 | 1qng (A) | 2 | 171 | 99.99 | 0 | 1 | 2.21 | -1.75 |
2 | 171 | 2hq6 (A) | 10 | 167 | 42.00 | 0 | 1 | 1.4 | -0.84 |
2 | 171 | 1qng (A) | 2 | 171 | 99.99 | 0 | 1 | 2.28995 | -2.03 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 8 hs, intra-erythrocytic - 16 hs, intra-erythrocytic - 24 hs, intra-erythrocytic - 32 hs, intra-erythrocytic - 40 hs, intra-erythrocytic - 48 hs, merozoite, sporozoite, early ring, early schizont, early trophozoite, late ring, late schizont, late trophozoite, Oocyst, Ring. | Otto TD PlasmoDB Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | gametocyte, Female Gametocyte, Male Gametocyte. | PlasmoDB Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | Sporozoite. | Zanghi G |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
Ortholog group members (OG5_126792)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G55920 | Cyclophilin-like peptidyl-prolyl cis-trans isomerase family protein |
Arabidopsis thaliana | AT2G21130 | peptidyl-prolyl cis-trans isomerase CYP19-2 |
Arabidopsis thaliana | AT4G34870 | rotamase cyclophilin 5 |
Arabidopsis thaliana | AT4G38740 | peptidyl-prolyl cis-trans isomerase CYP1 |
Babesia bovis | BBOV_IV005000 | cyclophilin, putative |
Brugia malayi | Bm1_46745 | cyclophilin-type peptidyl-prolyl cis-trans isomerase-3, Bmcyp-3 |
Brugia malayi | Bm1_55850 | cyclophilin-type peptidyl-prolyl cis-trans isomerase-2, Bmcyp-2 |
Candida albicans | CaO19.13826 | Cyclophilin type peptidyl-prolyl cis-trans isomerase similar to S. cerevisiae CPR1 (YDR155C) |
Candida albicans | CaO19_6472 | hypothetical protein |
Candida albicans | CaO19.6472 | Cyclophilin type peptidyl-prolyl cis-trans isomerase similar to S. cerevisiae CPR1 (YDR155C) |
Caenorhabditis elegans | CELE_Y75B12B.2 | Protein CYN-7 |
Caenorhabditis elegans | CELE_Y75B12B.5 | Protein CYN-3 |
Caenorhabditis elegans | CELE_Y49A3A.5 | Protein CYN-1 |
Caenorhabditis elegans | CELE_ZK520.5 | Protein CYN-2 |
Cryptosporidium hominis | Chro.20441 | 20k cyclophilin |
Cryptosporidium parvum | cgd2_4120 | 20k cyclophilin, putative |
Dictyostelium discoideum | DDB_G0282359 | cyclophilin-type peptidylprolyl cis-trans isomerase |
Drosophila melanogaster | Dmel_CG7768 | CG7768 gene product from transcript CG7768-RA |
Drosophila melanogaster | Dmel_CG9916 | Cyclophilin 1 |
Echinococcus granulosus | EgrG_000920600 | expressed protein |
Echinococcus multilocularis | EmuJ_000920600 | expressed protein |
Homo sapiens | 101060363 | peptidyl-prolyl cis-trans isomerase A-like |
Homo sapiens | ENSG00000108179 | peptidylprolyl isomerase F |
Homo sapiens | ENSG00000196262 | peptidylprolyl isomerase A (cyclophilin A) |
Homo sapiens | 650157 | peptidyl-prolyl cis-trans isomerase A-like |
Homo sapiens | 101928624 | peptidyl-prolyl cis-trans isomerase A-like |
Leishmania braziliensis | LbrM.33.1900 | cyclophilin 4, putative |
Leishmania braziliensis | LbrM.25.0790 | cyclophilin a |
Leishmania braziliensis | LbrM.23.0060 | cyclophilin 11, putative |
Leishmania donovani | LdBPK_331730.1 | cyclophilin, putative |
Leishmania donovani | LdBPK_230060.1 | cyclophilin, putative |
Leishmania donovani | LdBPK_250940.1 | cyclophilin a, putative |
Leishmania infantum | LinJ.23.0060 | cyclophilin 11, putative |
Leishmania infantum | LinJ.33.1730 | cyclophilin 4, putative |
Leishmania infantum | LinJ.25.0940 | cyclophilin a |
Leishmania major | LmjF.33.1630 | cyclophilin 4, putative |
Leishmania major | LmjF.23.0050 | cyclophilin 11, putative |
Leishmania major | LmjF.25.0910 | cyclophilin a |
Leishmania mexicana | LmxM.32.1630 | cyclophilin, putative |
Leishmania mexicana | LmxM.25.0910 | cyclophilin a |
Leishmania mexicana | LmxM.23.0050 | cyclophilin, putative,peptidyl-prolyl cis-trans isomerase, putative |
Loa Loa (eye worm) | LOAG_06740 | cyclophilin-type peptidyl-prolyl cis-trans isomerase-2 |
Loa Loa (eye worm) | LOAG_03625 | cyclophilin Ovcyp-2 |
Mus musculus | 268373 | peptidylprolyl isomerase A |
Mus musculus | ENSMUSG00000021868 | peptidylprolyl isomerase F (cyclophilin F) |
Neospora caninum | NCLIV_031040 | Peptidyl-prolyl cis-trans isomerase (EC 5.2.1.8), related |
Neospora caninum | NCLIV_019970 | Peptidyl-prolyl cis-trans isomerase A, related |
Oryza sativa | 4347920 | Os09g0571400 |
Oryza sativa | 4328121 | Os02g0121300 |
Onchocerca volvulus | OVOC9856 |
|
Onchocerca volvulus | OVOC11375 |
|
Plasmodium berghei | PBANKA_1216500 | peptidyl-prolyl cis-trans isomerase, putative |
Plasmodium falciparum | PF3D7_0322000 | peptidyl-prolyl cis-trans isomerase |
Plasmodium knowlesi | PKNH_0818800 | peptidyl-prolyl cis-trans isomerase, putative |
Plasmodium vivax | PVX_095135 | cyclophilin, putative |
Plasmodium vivax | PVX_220290 | unspecified product |
Plasmodium yoelii | PY03668 | peptidyl-prolyl cis-trans isomerase, cyclophilin-type |
Saccharomyces cerevisiae | YDR155C | peptidylprolyl isomerase CPR1 |
Schistosoma japonicum | Sjp_0001030 | ko:K01802 peptidylprolyl isomerase [EC5.2.1.8], putative |
Schistosoma mansoni | Smp_040130 | cyclophilin |
Schmidtea mediterranea | mk4.002269.05 | Peptidyl-prolyl cis-trans isomerase |
Schmidtea mediterranea | mk4.002976.00 | Peptidyl-prolyl cis-trans isomerase |
Schmidtea mediterranea | mk4.002269.03 | Peptidyl-prolyl cis-trans isomerase |
Schmidtea mediterranea | mk4.004974.02 | Peptidyl-prolyl cis-trans isomerase |
Schmidtea mediterranea | mk4.006784.02 | Peptidyl-prolyl cis-trans isomerase |
Schmidtea mediterranea | mk4.008473.01 | Peptidyl-prolyl cis-trans isomerase |
Schmidtea mediterranea | mk4.002499.01 | Peptidyl-prolyl cis-trans isomerase |
Trypanosoma brucei gambiense | Tbg972.11.920 | cyclophilin a,cyclophilin type peptidyl-prolyl cis-trans isomerase |
Trypanosoma brucei gambiense | Tbg.972.2.250 | cyclophilin-type peptidyl-prolyl cis-trans isomerase, putative,cyclophilin, putative |
Trypanosoma brucei gambiense | Tbg.972.2.170 | cyclophilin-type peptidyl-prolyl cis-trans isomerase, putative,cyclophilin, putative |
Trypanosoma brucei gambiense | Tbg972.8.1650 | cyclophilin type peptidyl-prolyl cis-trans isomerase, putative,peptidyl-prolyl cis-trans isomerase, putative |
Trypanosoma brucei | Tb927.11.880 | cyclophilin a |
Trypanosoma brucei | Tb927.8.2000 | cyclophilin, putative |
Trypanosoma brucei | Tb927.2.1560 | peptidyl-prolyl cis-trans isomerase, putative |
Trypanosoma brucei | Tb927.2.1680 | peptidyl-prolyl cis-trans isomerase, putative |
Trypanosoma congolense | TcIL3000_0_06330 | cyclophilin a, putative |
Trypanosoma congolense | TcIL3000_8_2030 | peptidyl-prolyl cis-trans isomerase, putative |
Trypanosoma congolense | TcIL3000_0_06320 | cyclophilin a, putative |
Trypanosoma congolense | TcIL3000.11.810 | cyclophilin a, putative |
Trypanosoma cruzi | TcCLB.509499.10 | cyclophilin, putative |
Trypanosoma cruzi | TcCLB.509215.40 | peptidyl-prolyl cis-trans isomerase, putative |
Trypanosoma cruzi | TcCLB.510259.50 | 21 kDa cyclophilin, putative |
Trypanosoma cruzi | TcCLB.506925.300 | cyclophilin type peptidyl-prolyl cis-trans isomerase |
Trypanosoma cruzi | TcCLB.510947.50 | rotamase, putative |
Toxoplasma gondii | TGME49_230520 | cyclophilin 1, putative |
Toxoplasma gondii | TGME49_205700 | cyclophilin precursor |
Theileria parva | TP01_0244 | cyclophilin 1 |
Trichomonas vaginalis | TVAG_137880 | peptidyl-prolyl cis-trans isomerase A, ppia, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.03.0250 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.03.0250 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.03.0250 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.03.0250 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb927.8.2000 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.8.2000 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.8.2000 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.8.2000 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_Y75B12B.2 | Caenorhabditis elegans | embryonic lethal | wormbase |
PBANKA_1216500 | Plasmodium berghei | Slow | plasmo |
TGME49_205700 | Toxoplasma gondii | Probably non-essential | sidik |
TGME49_230520 | Toxoplasma gondii | Probably non-essential | sidik |
TGME49_205700 | Toxoplasma gondii | Essentiality uncertain | sidik |
TGME49_230520 | Toxoplasma gondii | Essentiality uncertain | sidik |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
growth (GO:0040007) | lethal (sensu genetics) (PATO:0000718) | multi-cellular organism (CARO:0000012) | bloodstream stage (PLO:0040) | in vivo inhibition (TDR:00016) | Plasmodium falciparum | 375742 378360 406919 572633 572634 572635 |
Annotator: | saralph@unimelb.edu.au. | Comment: | 012/Mar/09. | References: | 9716503 | |
catalytic activity (GO:0003824) | decreased (PATO:0000468) | in vitro (MI:0492) | inferred from specific protein inhibition (ECO:0000020) | Plasmodium falciparum | 375742 378360 406919 572633 572634 572635 | |
Annotator: | saralph@unimelb.edu.au. | Comment: | 012/Mar/09. | References: | 9716503 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.6
Compound | Source | Reference |
---|---|---|
Curated by TDRTargets | References | |
Curated by TDRTargets | References | |
Curated by TDRTargets | References | |
Curated by TDRTargets | References | |
Curated by TDRTargets | References | |
Curated by TDRTargets | References |
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | peptidylprolyl isomerase F | Compounds | References |
Rattus norvegicus | Cyclophilin A | Compounds | References |
Target | Type | Source | Notes |
---|---|---|---|
PF3D7_0322000 | cloned gene | BRENDA | A gene with this EC number or name or sequence has been cloned from Plasmodium falciparum ( 3 ) |
13 literature references were collected for this gene.